Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU
Authors:
- Rui MaRMRui Ma
- Rong LuRLRong Lu
- Qiong XuQXQiong Xu
- Zhi-Feng ZhuZZZhi-Feng Zhu
- Li WangLWLi Wang
- Chun-Lei ZhouCZChun-Lei Zhou
- Xiao-Lei LiXLXiao-Lei Li
- Hua-Li ZhangHZHua-Li Zhang
- Zhi YaoZYZhi Yao
- 1 September 2008
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 269 (1) , 101-110
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Rapid and simple comparison of messenger rna levels using real-time PCRBiological Procedures Online, 2006
- Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiolCancer Letters, 2006
- Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2Molecular Cancer Therapeutics, 2005
- Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402Cancer Biology & Therapy, 2005
- Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrineCancer Chemotherapy and Pharmacology, 2004
- Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318Journal of Pharmacy and Pharmacology, 2004
- VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance ProteinClinical Cancer Research, 2004
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) geneCancer Chemotherapy and Pharmacology, 1997
- Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in CultureCancer Communications, 1991